Clinical Trial Update: Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C [NA]

View source ↗

Summary

Completed trial evaluating safety and efficacy of generic sofosbuvir with ribavirin for treatment-naive genotype 2 chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Kawin Technology Share-holding Co., Ltd. | Conditions: Hepatitis C, Chronic, Hepatitis C Virus Infection, Response to Therapy of | NA | Status: COMPLETED